RIGEL PHARMACEUTICALS INC - Common Stock, par value $0.001 per share (RIGL)

CUSIP: 766559702

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
18,470,418
Total 13F shares
12,067,467
Share change
+95,951
Total reported value
$202,977,408
Put/Call ratio
3%
Price per share
$16.82
Number of holders
114
Value change
+$2,514,731
Number of buys
71
Number of sells
27

Security key

766559702

Report period

Q4 2024

Institutions

114

Top holders

10

Top shareholders of RIGL - RIGEL PHARMACEUTICALS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Invesco Ltd.
13F 13D/G
Company
0.03%
from 13D/G
1,051,355
$17,010,924 30 Sep 2024
BlackRock, Inc.
13F
Company
8.5%
1,561,443
$25,264,147 30 Sep 2024
13F
ARMISTICE CAPITAL, LLC
13F
Company
8.3%
1,536,000
$24,852,480 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
7.9%
1,463,499
$23,679,414 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
5.3%
985,291
$15,942,009 30 Sep 2024
13F
Soleus Capital Management, L.P.
13F
Company
5.1%
934,788
$15,124,870 30 Sep 2024
13F
Assenagon Asset Management S.A.
13F
Company
2.4%
441,765
$7,147,758 30 Sep 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
2.3%
421,780
$6,823,000 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.2%
399,663
$6,467,966 30 Sep 2024
13F
STATE STREET CORP
13F
Company
2%
367,795
$5,950,923 30 Sep 2024
13F
Stonepine Capital Management, LLC
13F
Company
1.7%
309,100
$5,001,238 30 Sep 2024
13F
CM Management, LLC
13F
Company
1.6%
290,000
$4,692,200 30 Sep 2024
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
1.3%
240,968
$3,898,863 30 Sep 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.96%
177,340
$2,869,361 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.78%
144,251
$2,333,982 30 Sep 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.77%
141,946
$2,296,686 30 Sep 2024
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.63%
116,915
$1,891,685 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.62%
115,163
$1,863,338 30 Sep 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.53%
98,006
$1,585,737 30 Sep 2024
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.51%
94,549
$1,529,803 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.42%
77,407
$1,252,445 30 Sep 2024
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.4%
74,502
$1,205,442 30 Sep 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.35%
64,540
$1,044,257 30 Sep 2024
13F
FMR LLC
13F
Company
0.26%
48,105
$778,339 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.25%
46,113
$746,108 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.25%
45,523
$736,563 30 Sep 2024
13F
Squarepoint Ops LLC
13F
Company
0.25%
45,257
$732,258 30 Sep 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.21%
38,728
$626,619 30 Sep 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.17%
31,473
$509,233 30 Sep 2024
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.16%
28,860
$466,955 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.16%
28,646
$463,492 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
0.15%
27,345
$442,442 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.14%
26,238
$424,531 30 Sep 2024
13F
Man Group plc
13F
Company
0.14%
25,598
$414,176 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.14%
25,589
$414,030 30 Sep 2024
13F
STRS OHIO
13F
Company
0.13%
24,600
$398,028 30 Sep 2024
13F
Cubist Systematic Strategies, LLC
13F
Company
0.13%
24,264
$392,593 30 Sep 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.13%
23,658
$382,774 30 Sep 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.11%
21,008
$339,909 30 Sep 2024
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0.11%
20,012
$323,000 30 Sep 2024
13F
NJ State Employees Deferred Compensation Plan
13F
Company
0.11%
20,000
$323,600 30 Sep 2024
13F
PDT Partners, LLC
13F
Company
0.11%
19,914
$322,209 30 Sep 2024
13F
Hillsdale Investment Management Inc.
13F
Company
0.1%
18,600
$300,948 30 Sep 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.08%
15,565
$251,842 30 Sep 2024
13F
Jump Financial, LLC
13F
Company
0.08%
15,285
$247,311 30 Sep 2024
13F
Empire Financial Management Company, LLC
13F
Company
0.08%
14,250
$230,565 30 Sep 2024
13F
CITIGROUP INC
13F
Company
0.07%
13,357
$216,117 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.07%
12,766
$193,022 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.07%
12,414
$201,000 30 Sep 2024
13F
Connecticut Wealth Management, LLC
13F
Company
0.06%
11,520
$186,394 30 Sep 2024
13F

Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock, par value $0.001 per share (RIGL) as of Q4 2024

As of 31 Dec 2024, RIGEL PHARMACEUTICALS INC - Common Stock, par value $0.001 per share (RIGL) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,067,467 shares. The largest 10 holders included BlackRock, Inc., MORGAN STANLEY, ARMISTICE CAPITAL, LLC, Soleus Capital Management, L.P., VANGUARD GROUP INC, Assenagon Asset Management S.A., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 114 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
87
Q4 2024 holders
114
Holder diff
27
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .